KU 250 mg Pill - white capsule/oblong, 22mm
Pill with imprint KU 250 mg is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Kremers Urban Pharmaceuticals Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for KU 250 mg

Temozolomide
- Imprint
- KU 250 mg
- Strength
- 250 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Kremers Urban Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62175-0245
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
ferrosoferric oxide,
potassium hydroxide,
water
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.